LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1

Sabljić, Vladimir

Last name
Sabljić
First name
Vladimir
Country
-
  • Klinička ispitivanja u psihijatriji

    U članku su se pokušale razjasniti neke opće činjenice i noviji aspekti kliničkih ispitivanja. Klasifikacijski se klinička ispitivanja dijele na ona koja se baziraju na fazama kliničkog razvoja lijeka i na ona vezana uz tip i cilj studije. Između kliničkih ispitivanja po tipu ili po fazama postoji niz dodirnih točaka, ali i razlika. Unatoč sveprisutnom detaljnom obavještavanju bolesnika o ciljevima i načinima provođenja istraživanja te neovisnim ocjenama stručnih i eti...

    DULOXETINE-RELATED PANIC ATTACKS

    Side-effects arising on the grounds of antidepressant administration pose as a substantial obstacle hindering successful depressive disorder treatment. Side-effects, especially those severe or those manifested through dramatic clinical presentations such as panic attacks, make the treatment far more difficult and shake patients’ trust in both the treatment and the treating physician. This case report deals with a patient experiencing a moderately severe depressive episode, who respon...

    VENLAFAXINE WITHDRAWAL SYNDROME

    Dual-action antidepressants serotonin–norepinephrine reuptake inhibitors (SRNIs) are widely used to treat depression. Owing to its efficiency and safety, venlafaxine holds a prominent place in this group of depressants. Abrupt venlafaxine discontinuation involves a high risk of withdrawal syndrome. Mechanism of its development is similar to that of selective serotonin reuptake inhibitors (SSRIs), but of higher intensity. Venlafaxine withdrawal symptoms may include several somatic sym...

    WEIGHT GAIN - AS POSSIBLE PREDICTOR OF METABOLIC SYNDROME

    Rapid weight gain among patients with mental disorders can further compound psychological distress and negatively influence compliance. Weight gain associated with treatment with atypical antipsychotic medication has been widely recognized as a risk factor for the development of diabetes type II and cardiovascular diseases. This paper describes a 33-year old female patient treated for schizoaffective disorder. Within two months after introducing quetiapine the patient experienced ...

    HYPERPROLACTINAEMIA WITH AMISULPRIDE

    Psychopharmaca are used in treatment of psychiatric illnesses and disorders, among other therapeutic possibilities. The choice of the psychopharmaca is determined by the specific psychopathology of the patient, within the diagnostic categories, according to the current classification of diseases and disorders. With the advances in pharmaco industry, the range of drugs used in the everyday clinical practice is occurring at a very rapid pace. Antipsychotic medications are used in tr...

    SWITCHING AMONG ANTIPSYCHOTICS - FOCUS ON SIDE EFFECTS

    Depression is a disorder held responsible for high morbidity in the overall population. Causes of depression vary, but lifestyle and stress can greatly contribute to its morbidity. Consumption of antidepressants is showing a trend in the economically developed countries. Apart from antidepressants, the treatment of depression can consist of other psychopharmaca. Depending on the severity of a disorder, that is - of psychotic symptoms, antipsychotics can be introduced in the treatment...
  • No person research data found

Share - Bookmark